Sign up to newsletter

Featured Resources


Absolut Vapour Database

A database containing all references to the existing scientific studies related to ecigs

Blog Highlights

NSP | 10 October 2014 

Guide to the WHO Framework Convention on Tobacco Control meeting (Moscow, 13-18 October 2014)
This meeting is the Sixth Conference of the Parties (COP-6) to the Framework Convention on Tobacco Control (FCTC). This convention is WHO’s primary instrument for addressing the health impact of tobacco use internationally. This briefing provides information on discussions about electronic cigarettes and background documentation.

Clive Bates | 14 September 2014 

WHO position on ENDS - a critique of the use of science and communication of risk
A new paper is published today: WHO position on ENDS: a critique of the use of science and communication of risk (PDF) written and researched by Clive Bates at Counterfactual.
We have grown accustomed to WHO and the FCTC Secretariat taking a negative approach to tobacco harm reduction - seeing only risks and threats, and little of the real world potential, while covertly planning an offensive against e-cigarettes through the Framework Convention on Tobacco Control.

Neil McKeganey | 28 August 2014 

Scary Monsters. Have health professionals started a new moral panic over e-cigarettes?
There are few things more powerful than the narrative of fear. The concern that something may be harming us in ways that we might have been unaware, and that action should be taken to limit its occurrence, is a foundational tablet of interventionist public policy. The narrative of fear can be equally strong when it comes to new items that emerge in our social world and about which we know relatively little.

Gerry Stimson | 26 August 2014 

Statement on Tuesday´s publication of the World Health Organisation (WHO) Report on e-cigarettes
WHO’s mission is to save lives and prevent disease but once again it is exaggerating the risks of e-cigarettes, while downplaying the huge potential of these non-combustible low risk nicotine products to end the epidemic of tobacco related disease.

  • While public-health experts want e-cigarettes to be used as a quitting or "harm reduction" tool for hard-core smokers who could not quit otherwise, they also do not want e-cigarettes to induce nicotine addiction and provide a gateway to cigarettes among nonsmokers. As noble as this agenda can be, it means nothing in reality, since those who control the e-cigarette market have not and will not sign on it.
    2014-10-24 | orlandosentinel.com

    • E Cigarettes
    • USA
  • The study warns however that teenagers who regularly use cannabis, at least 50 times by the age of 15, may tend to do worse in exams. The Avon Longitudinal Study of Parents and Children followed 2,612 children born in the Bristol area in 1991 and 1992. Each child had their IQ tested at the ages of eight and again at 15, when they were also given a survey on cannabis use.
    2014-10-24 | independent.co.uk

    • Marijuana
    • U.K.
  • Mike Zhang, a professor of biological systems engineering [...] said the nicotine vaccine could ultimately be developed as a patch or nasal spray. Within several days of inoculation, patients would cease to experience the physiological pleasure that nicotine elicits in the brain. "Nicotine is one of the most dependency inducing drugs out there," said Zhang, "It's just as addictive as much harder drugs such as heroine or cocaine. [...]
    2014-10-24 | medicalxpress.com

    • Nicotine
    • Research
    • Study
  • Research out of the Center for Survey Research at the University of Massachusetts Boston suggests that policy makers and anti-smoking groups which are supporting bans on e-cigarette flavors - such as one proposed in New York City - would be violating this principle, causing tragic consequences by promoting smoking to a significant proportion of the population.
    2014-10-24 | tobaccoanalysis.blogspot.com

    • E Cigarettes
    • USA
  • Reynolds American RAI -0.59% announced that it will ban smoking from its offices starting next year. [...] The decision begs the question: What happens when your business practices and what you want your brand to represent are in conflict? The two women behind these recent decisions—Helena Foulkes, President of CVS/pharmacy and EVP of CVS Health, and Susan Cameron, President and CEO of Reynolds American—shared their thoughts [...]
    2014-10-24 | fortune.com

    • Smoke Free
    • USA
  • Over the years, the world has had to put up with tobacco, even though many people know that cigarette smoking can be harmful to one’s health. Some leading tobacco companies residing in the US have had an influence on smokers over the years. Apart from selling traditional cigarettes to the public, they spent millions in advertising their products in the hope of making big bucks.
    2014-10-24 | gurufocus.com

    • Industry
    • International
    • Tobacco
load more hold SHIFT key to load all load all

Nicotine Science and Policy posts news items on a wide range of issues related to the use of nicotine and posting of a news item does not imply endorsement of the views expressed in any item.


Upcoming Events

E-Cigarette Summit
Royal Society
London, UK
e-cig 2014
Policy, Health & Retail
London, UK

Who we are

imageNicotine Science and Policy
Nicotine Science and Policy is a new website devoted to news, research, comment and policy analysis on nicotine containing products, in particular nicotine delivery devices such as electronic cigarettes and other novel nicotine delivery systems, smokeless tobacco, and other non-combustible tobacco products.

About the Website



Analysis and discussion of current nicotine issues, by regular NSP correspondents and guests. . .



A-Z Lexicon of terms related to nicotine. . . .



A new resource on nicotine science and policy. A collaborative venture to provide a reference source on all matters related to nicotine. . . .

News Posts

A selection of English language media reports chosen from media searches and from NP correspondents.
. . .


Please send us your news, videos and other contributions and comments. . . .


Richard Ashcroft • Scott Ballin • Clive Bates • Karl Fagerström • Konstantinos Farsalinos • Jonathan Foulds • Coral Gartner • Joe Gitchell • Jacques Le Houezec • Delon Human • Lynn T. Kozlowski • Michael Kunze • Karl Lund • Riccardo Polosa • Lars Ramström • Gilbert Ross • Michael Siegel • Gerry Stimson • Dave Sweanor • Derek Yach